Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 30, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503).
Journal: Leukemia research
Published: March 18, 2025
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.
Journal: Leukemia & lymphoma
Published: December 17, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Journal: The New England journal of medicine
Published: July 24, 2024
Ph+ ALL in 2022: is there an optimal approach?
Journal: Hematology. American Society of Hematology. Education Program
Published: December 09, 2022
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: August 22, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 08, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 14, 2022
Last Updated: 09/26/2026